Bioptik Technology Incorporation (TPEX:4161)
Taiwan · Delayed Price · Currency is TWD 23.10
+0.10 (0.43%)
Aug 26, 2026, 11:16 AM CST
TPEX:4161 Financials Overview
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 912.86 | 837.19 | 865.34 | 828.5 | 767.75 | 737.89 |
Revenue Growth | 10.76% | -3.25% | 4.45% | 7.91% | 4.05% | 51.95% |
Gross Profit Gross Profit Growth | 257.09 | 243.51 | 267.91 | 239.54 | 177.46 | 163.55 |
Operating Income Operating Income Growth | 70.93 | 66.73 | 89.84 | 89.95 | 39.48 | 35.73 |
Net Income Net Income Growth | 108.52 | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 |
Earnings Per Share EPS Growth | 1.84 | 1.21 | 1.59 | 1.48 | 0.84 | 0.39 |
EPS Growth | 66.41% | -23.90% | 7.59% | 75.34% | 113.67% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Testing Equipment Medical Testing Equipment Growth | 772.84 | 674.8 | 634.23 | 556.84 | 553.21 | 629.6 |
Maintenance (Health) Products Department Maintenance (Health) Products Department Growth | 140.03 | 162.39 | 231.11 | 271.66 | 214.55 | 108.3 |
Total Total Growth | 912.86 | 837.19 | 865.34 | 828.5 | 767.75 | 737.89 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 442.58 | 448.38 | 422.29 | 394.13 | 332.61 | 344.85 |
Total Debt Total Debt Growth | 389.85 | 389.59 | 376.5 | 468.4 | 608.19 | 629.93 |
Net Cash (Debt) Net Cash Growth | 52.74 | 58.79 | 45.8 | -74.28 | -275.58 | -285.09 |
Net Cash Growth | 144.13% | 28.37% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.90 | 1.00 | 0.78 | -1.28 | -4.79 | -4.97 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 108.96 | 59.99 | 158.82 | 205.95 | 55.06 | -41.15 |
Capital Expenditures CapEx Growth | -20.64 | -19.17 | -14.93 | -30.42 | -16.93 | -19.14 |
Free Cash Flow Free Cash Flow Growth | 88.33 | 40.82 | 143.9 | 175.53 | 38.13 | -60.29 |
Free Cash Flow Growth | -17.52% | -71.63% | -18.02% | 360.35% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.16% | 29.09% | 30.96% | 28.91% | 23.11% | 22.16% |
Operating Margin | 7.77% | 7.97% | 10.38% | 10.86% | 5.14% | 4.84% |
Pretax Margin | 13.83% | 10.19% | 12.75% | 12.85% | 8.18% | 2.66% |
Profit Margin | 11.89% | 8.50% | 10.81% | 10.35% | 6.32% | 3.06% |
FCF Margin | 9.68% | 4.88% | 16.63% | 21.19% | 4.97% | -8.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.700 | 0.700 | 0.300 | 0.619 | - | 0.253 |
Dividend Per Share Growth | 133.26% | 133.33% | -51.57% | - | - | 0% |
Dividend Yield | 3.08% | 2.89% | 1.15% | 2.31% | - | 1.16% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.50 | 20.96 | 17.40 | 19.87 | 28.07 | 59.61 |
Forward PE | - | 51.86 | 51.86 | 51.86 | 51.86 | 51.86 |
P/FCF Ratio | 15.57 | 36.56 | 11.31 | 9.70 | 35.70 | - |
PS Ratio | 1.51 | 1.78 | 1.88 | 2.06 | 1.77 | 1.83 |